These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

487 related items for PubMed ID: 15569335

  • 1. Creatine supplementation does not decrease total plasma homocysteine in chronic hemodialysis patients.
    Taes YE, Delanghe JR, De Bacquer D, Langlois M, Stevens L, Geerolf I, Lameire NH, De Vriese AS.
    Kidney Int; 2004 Dec; 66(6):2422-8. PubMed ID: 15569335
    [Abstract] [Full Text] [Related]

  • 2. Controlled trials of very high dose folic acid, vitamins B12 and B6, intravenous folinic acid and serine for treatment of hyperhomocysteinemia in ESRD.
    Gonin JM, Nguyen H, Gonin R, Sarna A, Michels A, Masri-Imad F, Bommareddy G, Chassaing C, Wainer I, Loya A, Cary D, Barker LF, Assefi A, Greenspan R, Mahoney D, Wilcox CS.
    J Nephrol; 2003 Dec; 16(4):522-34. PubMed ID: 14696754
    [Abstract] [Full Text] [Related]

  • 3. Efficacy of folate and vitamin B12 in lowering homocysteine concentrations in hemodialysis patients.
    Azadibakhsh N, Hosseini RS, Atabak S, Nateghiyan N, Golestan B, Rad AH.
    Saudi J Kidney Dis Transpl; 2009 Sep; 20(5):779-88. PubMed ID: 19736473
    [Abstract] [Full Text] [Related]

  • 4. Hyperhomocysteinemia in hemodialysis patients: effects of 12-month supplementation with hydrosoluble vitamins.
    Tremblay R, Bonnardeaux A, Geadah D, Busque L, Lebrun M, Ouimet D, Leblanc M.
    Kidney Int; 2000 Aug; 58(2):851-8. PubMed ID: 10916110
    [Abstract] [Full Text] [Related]

  • 5. [The treatment of hyperhomocysteinemia in patients on dialysis: folic acid or the high-flow polysulphonic membrane?].
    Lovcić V, Kes P, Zeljko R, Kusec V.
    Acta Med Croatica; 2006 Jun; 60(3):201-8. PubMed ID: 16933832
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Efficacy and safety of two vitamin supplement regimens on homocysteine levels in hemodialysis patients. Prospective, randomized clinical trial].
    Sánchez Alvarez JE, Pérez Tamajón L, Hernández D, Alvarez González A, Delgado P, Lorenzo V.
    Nefrologia; 2005 Jun; 25(3):288-96. PubMed ID: 16053010
    [Abstract] [Full Text] [Related]

  • 8. [The effect of lowering plasma homocysteine levels on some parameters of thrombotic activity in haemodialyzed patients with chronic renal failure].
    Kozłowska I.
    Ann Acad Med Stetin; 2004 Jun; 50(1):87-95. PubMed ID: 16871747
    [Abstract] [Full Text] [Related]

  • 9. Effect of short-term folate and vitamin B supplementation on blood homocysteine level and carotid artery wall thickness in chronic hemodialysis patients.
    Tungkasereerak P, Ong-ajyooth L, Chaiyasoot W, Ong-ajyooth S, Leowattana W, Vasuvattakul S, Vareesangthip K, Shayakul C, Chanchairujira T, Sritippayawan S.
    J Med Assoc Thai; 2006 Aug; 89(8):1187-93. PubMed ID: 17048428
    [Abstract] [Full Text] [Related]

  • 10. Homocysteine lowering effect of different multivitamin preparations in patients with end-stage renal disease.
    Dierkes J, Domröse U, Bosselmann KP, Neumann KH, Luley C.
    J Ren Nutr; 2001 Apr; 11(2):67-72. PubMed ID: 11295026
    [Abstract] [Full Text] [Related]

  • 11. Comparative study of response to treatment with supraphysiologic doses of B-vitamins in hyperhomocysteinemic hemodialysis patients.
    Nakhoul F, Abassi Z, Plawner M, Khankin E, Ramadan R, Lanir N, Brenner B, Green J.
    Isr Med Assoc J; 2004 Apr; 6(4):213-7. PubMed ID: 15115259
    [Abstract] [Full Text] [Related]

  • 12. Hyperhomocysteinaemia, folate and vitamin B12 in unsupplemented haemodialysis patients: effect of oral therapy with folic acid and vitamin B12.
    Billion S, Tribout B, Cadet E, Queinnec C, Rochette J, Wheatley P, Bataille P.
    Nephrol Dial Transplant; 2002 Mar; 17(3):455-61. PubMed ID: 11865092
    [Abstract] [Full Text] [Related]

  • 13. Treatment of hyperhomocysteinemia in hemodialysis patients and renal transplant recipients.
    Bostom AG, Shemin D, Gohh RY, Beaulieu AJ, Bagley P, Massy ZA, Jacques PF, Dworkin L, Selhub J.
    Kidney Int Suppl; 2001 Feb; 78():S246-52. PubMed ID: 11169020
    [Abstract] [Full Text] [Related]

  • 14. Response of hyperhomocysteinemia to folic acid supplementation in patients with end-stage renal disease.
    Dierkes J, Domröse U, Ambrosch A, Bosselmann HP, Neumann KH, Luley C.
    Clin Nephrol; 1999 Feb; 51(2):108-15. PubMed ID: 10069646
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The C677T MTHFR genotypes influence the efficacy of B9 and B12 vitamins supplementation to lowering plasma total homocysteine in hemodialysis.
    Achour O, Elmtaoua S, Zellama D, Omezzine A, Moussa A, Rejeb J, Boumaiza I, Bouacida L, Rejeb NB, Achour A, Bouslama A.
    J Nephrol; 2016 Oct; 29(5):691-8. PubMed ID: 26559681
    [Abstract] [Full Text] [Related]

  • 17. Oral vitamin B12 supplementation reduces plasma total homocysteine concentration in women in India.
    Yajnik CS, Lubree HG, Thuse NV, Ramdas LV, Deshpande SS, Deshpande VU, Deshpande JA, Uradey BS, Ganpule AA, Naik SS, Joshi NP, Farrant H, Refsum H.
    Asia Pac J Clin Nutr; 2007 Oct; 16(1):103-9. PubMed ID: 17215186
    [Abstract] [Full Text] [Related]

  • 18. Homocysteine-lowering vitamins do not lower plasma S-adenosylhomocysteine in older people with elevated homocysteine concentrations.
    Green TJ, Skeaff CM, McMahon JA, Venn BJ, Williams SM, Devlin AM, Innis SM.
    Br J Nutr; 2010 Jun; 103(11):1629-34. PubMed ID: 20089204
    [Abstract] [Full Text] [Related]

  • 19. Parenteral vitamin B12 reduces hyperhomocysteinemia in end-stage renal disease.
    Kaplan LN, Mamer OA, Hoffer LJ.
    Clin Invest Med; 2001 Feb; 24(1):5-11. PubMed ID: 11266032
    [Abstract] [Full Text] [Related]

  • 20. Vitamin B12 decreases, but does not normalize, homocysteine and methylmalonic acid in end-stage renal disease: a link with glycine metabolism and possible explanation of hyperhomocysteinemia in end-stage renal disease.
    Hyndman ME, Manns BJ, Snyder FF, Bridge PJ, Scott-Douglas NW, Fung E, Parsons HG.
    Metabolism; 2003 Feb; 52(2):168-72. PubMed ID: 12601627
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.